VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 43 filers reported holding VIRIDIAN THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,179,171 | -39.6% | 1,380,650 | -6.3% | 0.01% | -35.3% |
| Q2 2023 | $35,049,522 | +224260.0% | 1,473,288 | +139.9% | 0.02% | +88.9% |
| Q1 2023 | $15,622 | -39.0% | 614,089 | -29.9% | 0.01% | -35.7% |
| Q4 2022 | $25,596 | -99.8% | 876,254 | +15.0% | 0.01% | +55.6% |
| Q3 2022 | $15,630,000 | +20.0% | 762,060 | -32.3% | 0.01% | +12.5% |
| Q2 2022 | $13,029,000 | -27.8% | 1,126,085 | +15.4% | 0.01% | -20.0% |
| Q1 2022 | $18,039,000 | +97.3% | 975,618 | +111.0% | 0.01% | +100.0% |
| Q4 2021 | $9,141,000 | +244.4% | 462,390 | +186.6% | 0.01% | +150.0% |
| Q3 2021 | $2,654,000 | +23.3% | 161,345 | +37.1% | 0.00% | +100.0% |
| Q2 2021 | $2,153,000 | +198.6% | 117,715 | +172.6% | 0.00% | 0.0% |
| Q1 2021 | $721,000 | – | 43,176 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 2,699,865 | $68,684,566 | 13.41% |
| COMMODORE CAPITAL LP | 2,189,659 | $55,704,925 | 8.48% |
| Fairmount Funds Management LLC | 1,369,623 | $34,843,209 | 5.99% |
| Paradigm Biocapital Advisors LP | 2,085,698 | $53,060,157 | 5.03% |
| Octagon Capital Advisors LP | 1,185,000 | $30,146,400 | 4.34% |
| Logos Global Management LP | 950,000 | $24,168,000 | 3.46% |
| TCG Crossover Management, LLC | 663,610 | $16,882,238 | 3.29% |
| ACUTA CAPITAL PARTNERS, LLC | 168,000 | $4,273,920 | 3.15% |
| Vivo Capital, LLC | 1,678,207 | $42,693,586 | 2.96% |
| TANG CAPITAL MANAGEMENT LLC | 692,925 | $17,628,012 | 2.63% |